Your browser doesn't support javascript.
loading
Managing the Dual Diagnosis Dilemma of Bipolar Disorder and Substance Abuse in Clinical Settings.
Samimi Ardestani, Seyed Mehdi; Amin-Esmaeili, Masoumeh; Seif, Pegah; Gudarzi, Shahrokh S; Rafiefarahzadi, Maliheh; Semnani, Yousef.
Afiliação
  • Samimi Ardestani SM; Department of Psychiatry, School of Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Amin-Esmaeili M; Associate Professor of Psychiatry, Iranian National Center for Addiction Studies (INCAS), Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
  • Seif P; Postdoc Research Fellowship, Beth Israel Deaconess Medical Center, Harvard University, Boston, Massachusetts, USA.
  • Gudarzi SS; Eastern Health, Melbourne, Australia.
  • Rafiefarahzadi M; Private Practice Psychiatrist, Tehran, Iran.
  • Semnani Y; Department of Psychiatry, School of Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
J Dual Diagn ; 20(2): 178-187, 2024.
Article em En | MEDLINE | ID: mdl-38502951
ABSTRACT

OBJECTIVE:

Drug addiction is a chronic mental disorder that significantly impacts all aspects of an individual's life, and substance use disorder in patients with bipolar disorder. The objective of this study is to assess the frequency of substance abuse among patients with bipolar spectrum disorder.

METHOD:

This cross-sectional study evaluated the frequency of bipolar spectrum disorder in patients taking methadone through various screening measures, including Mini Mental State Examination (MMSE), DSM IV criteria, Mood Disorders Questionnaire (MDQ), Goodwin and Ghaemi's criteria, and Akiskal classification for bipolar disorders.

RESULTS:

Out of the total 197 participants in the study, 77 were identified as individuals engaging in poly-substance abuse. The investigation assessed the frequency of bipolar spectrum disorder based on various diagnostic criteria 24% according to DSM-IV criteria, 29.9% using MDQ, 29.9% based on Ghaemi and Goodwin's criteria, and the highest rate at 48.2% when applying Akiskal's classification.

CONCLUSIONS:

This study highlights the high frequency of bipolar disorder among individuals with substance use disorder, especially those with concomitant depression. Therefore, it is crucial to pay special attention to individuals with substance use disorder with co-existing bipolar disorder.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Transtornos Relacionados ao Uso de Substâncias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Transtornos Relacionados ao Uso de Substâncias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article